Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Latest filing published 02 Jun 2023 for Centessa Pharmaceuticals plc, €27k. Read the official filing
Filing timeline
BuySaleAntoine Yver
Insider track record
Disclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Antoine Yver: trading record in brief
Antoine Yver is a declared insider of Centessa Pharmaceuticals plc (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 27 May 2021 to 1 June 2023, the count stands at 18 filings.
Sales make up the whole of the open-market record (13 sales, €575k). Besides market trades, the filings include 5 share grants. So far in 2023, the count stands at no purchases and 3 sales.
The newest entry dates from 2 June 2023: an open-market sale of €27k, in Centessa Pharmaceuticals plc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Antoine Yver
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
6,500 shares@ US$4.45374.3% of flowOrdinary SharesSEC:0001847903-23-000104:0
6,800 shares@ US$4.4244.4% of flowOrdinary SharesSEC:0001847903-23-000090:0
3,615 shares@ US$3.902.1% of flowOrdinary SharesSEC:0001847903-23-000082:0
7,000 shares@ US$3.42433.6% of flowOrdinary SharesSEC:0001847903-23-000054:0
77,200 shares0Ordinary SharesSEC:0001847903-23-000045:0
7,732 shares@ US$4.255.3% of flowOrdinary SharesSEC:0001847903-23-000025:0
2,268 shares@ US$3.101.0% of flowOrdinary SharesSEC:0001847903-23-000016:0
9,400 shares@ US$3.90895.6% of flowOrdinary SharesSEC:0001847903-22-000109:0
9,500 shares@ US$3.90616.0% of flowOrdinary SharesSEC:0001847903-22-000096:0
9,700 shares@ US$4.02636.3% of flowOrdinary SharesSEC:0001847903-22-000076:0
2,468 shares@ US$4.06741.6% of flowOrdinary SharesSEC:0001847903-22-000065:0
10,423 shares@ US$4.41217.4% of flowOrdinary SharesSEC:0000899243-22-030302:0
10,423 shares@ US$4.45227.2% of flowOrdinary SharesSEC:0000899243-22-027633:0
20,000 shares@ US$4.865615.3% of flowOrdinary SharesSEC:0000899243-22-026421:0
9,100 shares@ US$5.03267.0% of flowOrdinary SharesSEC:0000899243-22-025479:0
9,200 shares@ US$4.67780.0007% mcap28.2% of flowOrdinary SharesSEC:0000899243-22-023485:0
20,222 shares@ US$5.42140.0017% mcap71.8% of flowOrdinary SharesSEC:0000899243-22-018913:0
833,897 shares0Ordinary SharesSEC:0000899243-21-021436:0
18 of 18 declarations
